Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 245 de 371.

Grafa
Transport and logistics

AerCap and Ethiopian Airlines sign landmark lease for Africa’s first 777-300ERSF freighters

AerCap Holdings (NYSE:AER), the world’s largest aircraft lessor, has announced the signing of lease agreements with Ethiopian Airlines for two Boeing 777-300ERSF converted freighters.

Leia mais: AerCap and Ethiopian Airlines sign landmark lease for Africa’s first 777-300ERSF freighters
Grafa
Technology

Cheetah Mobile reports 43% revenue surge as AI segment now comprises nearly half of total business

Cheetah Mobile (NYSE:CMCM) today reported unaudited financial results for the full year ended December 31, 2025, marking a definitive milestone in its multi-year strategic pivot toward artificial intelligence.

Leia mais: Cheetah Mobile reports 43% revenue surge as AI segment now comprises nearly half of total business
Grafa

Regeneron and Sanofi secure historic seventh Japanese indication for Dupixent in bullous pemphigoid

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Dupixent (dupilumab) for the treatment of adults with moderate-to-severe bullous pemphigoid (BP) whose disease is not adequately controlled by existing therapies.

Leia mais: Regeneron and Sanofi secure historic seventh Japanese indication for Dupixent in bullous pemphigoid
Grafa
Health

Pharming Group secures first-ever APDS treatment approval in Japan for patients 4+

Pharming Group (NASDAQ:PHAR) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted marketing approval for Joenja (leniolisib) as the first targeted treatment for activated phosphoinositide 3-kinase delta syndrome (APDS).

Leia mais: Pharming Group secures first-ever APDS treatment approval in Japan for patients 4+
Grafa

Pyxis Oncology completes MICVO enrollment and appoints new interim leadership

Pyxis Oncology (NASDAQ:PYXS), a clinical-stage biopharmaceutical company focused on next-generation therapeutics for difficult-to-treat cancers, announced it has completed target enrollment of approximately 40 patients in the Phase 1 monotherapy dose-expansion cohort of micvotabart pelidotin (MICVO) in patients with second-line or later recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Leia mais: Pyxis Oncology completes MICVO enrollment and appoints new interim leadership
Grafa
Technology

Mobilicom achieves record liquidity and tier-1 defense integration in breakthrough 2025

Mobilicom (NASDAQ:MOB) today announced its financial and operating results for the full year ended December 31, 2025, revealing a strengthened balance sheet and significant commercial momentum within the U.S. defense sector.

Leia mais: Mobilicom achieves record liquidity and tier-1 defense integration in breakthrough 2025
Grafa
Health

Abivax fortifies balance sheet with €530M cash runway ahead of critical Phase 3 data

Abivax (NASDAQ:ABVX) today announced its full-year 2025 financial results and provided a comprehensive corporate update, underscored by a significantly strengthened capital structure and steady clinical progress.

Leia mais: Abivax fortifies balance sheet with €530M cash runway ahead of critical Phase 3 data
Grafa
Technology

Victory Capital slams "inferior" Trian bid, defends $57.05 Janus Henderson proposal

Victory Capital Holdings (NASDAQ:VCTR) issued a sharp rebuttal today against the Special Committee of Janus Henderson Group (NYSE:JHG), seeking to "set the record straight" regarding its $57.05 per share acquisition proposal.

Leia mais: Victory Capital slams "inferior" Trian bid, defends $57.05 Janus Henderson proposal